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Vitamin C Reduces Ischaemia-reperfusion-induced Acute Lung Injury
S. R. Kearns, C. J. Kelly*, M. Barry, H. Abdih, C. Condron, A. Leahy and D. Bouchier-Hayes
Department of Surgery, Royal College of Surgeons in Ireland, Beaumont Hospital, Beaumont Road, Dublin 9, Ireland
Objectives: to evaluate vitamin C supplementation in the prevention of ischaemia-reperfusion (I-R) induced acute lung
injury.
Design: Sprague–Dawley rats (n=6/group) were randomised into Control, I-R and I-R pretreated with vitamin C (3.3 g
over 5 days). Ischaemia-reperfusion injury was induced by 30 minutes infrarenal aortic cross-clamping and 120 minutes
reperfusion.
Methods: pulmonary microvascular injury was measured by broncho-alveolar lavage protein concentration, pulmonary
neutrophil infiltration by tissue myeloperoxidase activity and bronchoalveolar lavage neutrophil counts. In a second
experiment (n=5/group) neutrophil respiratory burst activity was measured in Control and vitamin C groups.
Results: ischaemia-reperfusion resulted in a significant increase in both microvascular leakage and pulmonary neutrophil
infiltration as measured by bronchoalveolar lavage protein concentration and pulmonary myeloperoxidase activity
respectively. Pretreatment with vitamin C significantly attenuated both microvascular leakage and neutrophil infiltration.
Neutrophil respiratory burst activity was significantly reduced in the vitamin C group (13.02 m.c.f.–0.3) compared with
Control (19.04 m.c.f.–1.9), p<0.02.
Conclusion: these data suggest that oral vitamin C therapy protects against ischaemia-reperfusion-induced acute lung
injury, possibly by attenuating neutrophil respiratory burst activity.
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Introduction to protect against this oxidant-mediated endothelial
injury in vivo.7
Aortic surgery results in an ischaemia-reperfusion in- The aim of this study was to investigate whether
supplementation with oral vitamin C attenuates isch-jury characterised by local injury and a systemic in-
flammatory response. This results in renal, cardiac and aemia-reperfusion-induced acute lung injury in a ro-
dent model of aortic cross-clamping and reperfusion.pulmonary microvascular injury.1,2
This systemic inflammatory injury is in part a
neutrophil-mediated process. Activated neutrophils
Methodsadhere to endothelium and migrate into the tissues
releasing reactive oxygen species and cytokines, caus-
Study 1ing interstitial tissue injury.3–5 Previous studies by
Barry et al. have shown that antioxidants like taurine
Animal preparation. Eighteen Sprague–Dawley rats eachcan reduce this injury.6 weighing 300–400 g were randomised into one of threeVitamin C is an endogenous antioxidant; it acts as groups:an antioxidant by scavenging aqueous phase-reactive
1. Control – normal diet;oxygen species (ROS) by very rapid electron trans-
2. Ischaemia-reperfusion (I-R) – normal diet;fer.7,8 Patients with peripheral vascular disease have
3. Ischaemia-reperfusion (I-R) with supplemental vit-been shown to be deficient in endogenous antioxidants
amin C (Roche Pharmaceuticals).such as carotenes, vitamin E and vitamin C.9 There is
evidence of continuous oxidant injury in smokers, Feed was standard chow (Red Mills, Eire) containing
with increased lipid peroxidation.9,10 Thus, patients 60 I.U. vitamin E per kg. Each animal received 3.3 g
undergoing vascular reconstructive surgery are of vitamin C in five divided doses administered in
potentially both deficient in endogenous antioxidants 33 ml of drinking water for the 5-day period prior to
and exposed to oxidant reperfusion injury. Sup- surgery. Residual volumes of water at the end of each
plementation with vitamin C has been demonstrated day were noted.
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Experimental protocol. The animals were anaesthetisedUnit, Department of Surgery, Beaumont Hospital, Beaumont,
Ireland. with inhalational halothane. A jugular venous catheter
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was inserted for heparin administration. All animals are The animals were culled at day 5 and whole blood
taken for estimation of respiratory burst activity.maintained supine for the duration of the experiment.
Core temperature was measured for the duration of the
experiment using a rectal temperature probe. Neutrophil respiratory burst activity. Blood was taken
via cannulation of the right ventricle with a 25-gaugeAortic occlusion and reperfusion. Anaesthetised animals
needle and assayed within 4 hours. The respiratoryunderwent a midline laparotomy. Following systemic
burst was assessed using a Bursttest (Orpegen,heparinisation (400 I.U./kg) the infrarenal aorta was
Heidelberg, Germany). This method allows the deter-identified and clamped for 30 minutes using a micro-
mination of leucocyte oxidative and enzymatic activityvascular clamp. In control cases the aorta was exposed
using dihydrorhodamine 123 (DR 123) as a fluorogenicbut not clamped.
substrate, and measures flow cytometrically. WholeAfter reperfusion for 2 hours the animals were killed
blood (100 ll) was incubated alone or with 10 ll ratby anaesthetic overdose. A sternotomy was performed
serum opsonised Escherichia coli for 10 minutes: 10 lland the left main bronchus exposed and clamped.
DHR 123 was then added and incubation continuedBronchoalveolar lavage (BAL) of the right lung was
for a further 10 minutes. The analysis of respiratoryperformed with 2 ml saline containing 0.07 M EDTA,
burst activity was performed on a Fascan (fluorescenceand repeated three times. The combined lavage fluid
activated cell sorting) cytofluorometer (Becton-Dickin-was cold-centrifuged at 1500 g for 20 minutes, frozen
son, USA) detecting mean channel fluorescence. Aat -20 °C and subsequently assayed for protein con-
minimum of 5000 cells was collected and analysedcentration.6
using the Lysis II software (California, USA).14
Myeloperoxidase assay. Myeloperoxidase (MPO) is a
haem-containing enzyme contained in the azurophil Statistical analysis. Results were expressed as mean
granules of neutrophils. Its measurement has been –s.e.m. in text and figures. Results were analysed
shown previously to be a simple method of quant- using the analysis of variance for the comparison of
itatively assessing tissue neutrophil sequestration. The multiple means (ANOVA) with post hoc Scheffe test
right ventricle was cannulated using a 25-gauge needle analysis. Significance was accepted at the p<0.05 level.
and the right pulmonary hilum clamped. The left pul-
monary vasculature was flushed using 50 ml of normal
Resultssaline to clear the lung of intravascular neutrophils.6,11
After weighing, the left lung was homogenised in 10 ml
Effect of ischaemia-reperfusion on pulmonary neutrophilof 0.5% hexadecyltrimethyl ammonium bromide in
infiltration50 mmol/l potassium phosphate buffer at pH 6. The
homogenate was freeze-thawed twice and centrifuged
Ischaemia followed by reperfusion resulted in a sig-at 12 000 g for 15 minutes. The resultant supernatant
nificant increase in pulmonary neutrophil infiltrationwas assayed spectrophotometrically for MPO activity
as indicated by an increase in MPO activity fromby incubating 10 ll of the supernatant with 290 ll of a
5.38–0.6 U/g in control animals to 8.21–0.65 U/g insolution containing 2.9 ml of O-dioniside dihydro-
the I-R group (p<0.05). This rise was significantlychloride in 90 ml distilled water. 10 ml 50 mmol/l potas-
reduced by pretreatment with oral vitamin Csium phosphate buffer (pH 6) and hydrogen peroxide.
(5.14–1.03 U/g) (p<0.05 ANOVA) (Fig. 1). Ischaemia-The change in absorbance with time was then measured
reperfusion also caused a significant increase inat 450 nm. One unit of MPO was defined as that de-
bronchoalveolar lavage neutrophil concentrationgrading 1 lmol of peroxide per minute at 25 °C.12
(22.3–2.8/mm3; p<0.01 vs. control). Pretreatment with
Bronchoalveolar lavage. Lung lavage fluid protein vitamin C significantly reduced neutrophil concentra-
concentration was measured spectrophotometrically tion in bronchoalveolar lavage fluid (5.8–1.1/mm3,
using the Lowry method.13 Neutrophil counts in BAL p<0.01 vs. control and I-R groups).
fluid were assessed by Diff–Quick staining and con-
secutive counting of neutrophils per high-power field. Effect of ischaemia-reperfusion on pulmonary
microvascular permeability
Study 2
Pulmonary microvascular permeability, as assessed
by bronchoalveolar lavage protein concentration, wasIn a second experiment 12 animals were randomly
assigned to either normal diet or supplement vitamin significantly elevated in untreated animals versus
controls and vitamin C pretreated groups. ProteinC (3.3 g oral vitamin C over 5 days).
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The results of this study demonstrate that lower
torso ischaemia results in a significant pulmonary
microvascular injury (increased BAL, WCC and pro-
tein concentration), associated with pulmonary neutro-
phil infiltration (increased myeloperoxidase activity).
Oral presupplementation with the antioxidant vitamin
C was associated with a significant reduction in
pulmonary microvascular leakage and neutrophil
infiltration. Furthermore, in a second series of ex-
periments, oral supplementation with vitamin C was
found to reduce neutrophil respiratory burst activity.
These data suggest that vitamin C prevents ischaemia-
reperfusion-induced injury through decreasing
Fig. 1. Effect of ischaemia-reperfusion on pulmonary myelo- neutrophil and oxidant-mediated tissue injury.
peroxidase activity. Data is expressed as mean–s.e.m. * p <0.05 vs.
Welbourn et al. and other authors have shown isch-I-R (ANOVA).
aemia-reperfusion-induced pulmonary injury to be a
concentrations were 434–80.1 lg/ml in the I-R group neutrophil-mediated oxidant injury.1–4,6 Neutrophils
versus 169.2–24.9 lg/ml in the control group (p<0.02 are activated in the circulation, adhere to and migrate
vs. I-R). In the vitamin C group the rise in protein across the endothelium releasing reactive oxygen spe-
concentration seen in the untreated group follow- cies.7 It is these reactive oxygen species (e.g. super-
ing reperfusion was significantly reduced to oxide) that cause tissue injury detectable as oxidised
196.9–32.6 lg/ml (p<0.02 vs. I-R) (Fig. 2). lipid.7 Furthermore, Khaira et al. have demonstrated
antioxidant depletion both during and after aortic-
aneurysm repair suggesting consumption of anti-
Neutrophil respiratory burst activity oxidants in the circulation by this process.15 Spark et
al. have shown that reduced levels of antioxidantsIn a separate experiment pretreatment with vitamin
predicted ischaemia-reperfusion injury after femoro-C significantly reduced neutrophil respiratory burst
distal bypass.16 Authors like Barry et al. have dem-activity (13.02–0.3 m.c.f.; p<0.01 vs. control) compared
onstrated that ischaemia-reperfusion-induced injurywith an untreated control group (19.01–1.9 m.c.f.).
may be attenuated by supplementation with oral anti-
oxidants such as the amino acid taurine.6
Vitamin C is a water-soluble endogenous anti-Discussion
oxidant; when given orally in a human population
plasma concentrations rapidly reach a steady state atOur hypothesis was that oral administration of vitamin
doses greater than 200 mg per day. Neutrophils sat-C, an endogenous antioxidant, would attenuate isch-
urate at doses greater than 100 mg per day to levelsaemia-reperfusion injury.
fourteen times that of plasma.18 The oral dosage re-
gimen of vitamin C selected for this study is based
on previous work showing prevention of leucocyte
adhesion to microvascular endothelium following ex-
posure to oxidised LDL at a dose of approximately
1 g per day7 and a review of previous regimens and
their efficacy and side-effects in animal and human
populations at doses between 200 mg and 3 g per day.19
Vitamin C exerts its antioxidant effect by scavenging
reactive oxygen species by very rapid aqueous phase
electron transfer, preventing initiation of lipid per-
oxidation.6,21–23 Smokers have been demonstrated to
excessively utilise circulating antioxidants including
vitamins C and E and, consequently, to have lower
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Fig. 2. Effect of ischaemia-reperfusion on bronchoalveolar lavage pared to the rest of the population.9,10protein concentration. Data is expressed as mean–s.e.m. * p <0.02
vs. I-R (ANOVA). Vitamin C, similarly to the antioxidant amino acid
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4 Welbourn CRB, Goldman G, Peterson IS et al. Patho-taurine preferentially concentrates in circulating
physiology of ischaemia reperfusion injury: central role of theneutrophils.16,18 Lehr et al. have shown that vitamin C neutrophil. Br J Surg 1991; 78: 651–655.
5 Thompson MM, Nasima A, Sayers RD et al. Oxygen free radicalprotects against neutrophil adhesion to the micro-
and cytokine generation during endovascular and conventionalvascular endothelium, thus preventing injury to
aneurysm repair. Eur J Vasc Endovasc Surg 1996; 12: 70–75.the microvascular circulation.7 Furthermore, Her- 6 Barry MC, Kelly CJ, Abdih H et al. Differential effects of lower
limb revascularisation on organ injury and the role of the aminobaczynska-Cedro et al. have demonstrated that vitamin
acid taurine. Eur J Vasc Endovasc Surg 1997; 13: 193–201.C reduces oxygen free-radical production in human
7 Lehr HA, Frei B, Olofsson M et al. Protection from oxidisedcirculating neutrophils.20 The findings of this study LDL-induced leukocyte adhesion to microvascular and macro-
vascular endothelium in vivo by vitamin C but not by vitaminsupport these studies, in that vitamin C reduced both
E. Circulation 1995; 91: 1525–1532.the microvascular pulmonary injury induced by isch-
8 Winklhofer-Roob BM, Ellemunter H, Fruwirth M et al.aemia-reperfusion and respiratory burst activity of Plasma vitamin C concentration in patients with cystic fibrosis:
evidence of associations with lung inflammation. Am J Clin Nutrcirculating neutrophils.
1997; 65: 1858–1866.Vitamin C would seem like an ideal agent for anti-
9 Chow CK, Thacker RR, Changit C et al. Lower levels of Vitaminoxidant therapy in that it is an endogenous agent, and C and carotenes in plasma of cigarette smokers. J Am Coll Nutr
1986; 5: 305–312.in that it may be given orally and parenterally with
10 Frei B, Forte TM, Ames BN, Cross CE. Gas phase oxidantsvery similar efficacy.7 However, recent studies in
of cigarette smoke induce lipid peroxidation and changes inhuman subjects have raised concerns over the potential lipoprotein properties in human blood plasma. Protective effects
of ascorbic acid. Biochemical Journal 1991; 277: 133–138.toxicity of long-term therapy. Treatment with dosages
11 Javadpour M, Kelly CJ, Chen G et al. Thermotolerance inducesof 500 mg per day for six weeks caused increased levels
heat shock protein 72 expression and protects against ischaemia-of 8-oxoadenosine, a potentially mutogenic lesion.24 reperfusion-induced lung injury. Br J Surg 1998; 85: 943–946.
12 Laight DW, Lad N, Woodward B, Waterfall JF. AssessmentHowever, doses of less than 500 mg per day seem
of myeloperoxidase activity in renal tissue after ischaemia/to have an antioxidant effect and multiple trials have
reperfusion. Eur J Pharmacol 1994; 292: 81–88.shown safety and, indeed, anticarcinogenic properties 13 Lowry OH, Rosenrough NJ, Farr AL, Randall RJ. Protein
measurement with the Folin phenol reagent. J Biol Chem 1951;for doses of vitamin C of between 200 and 400 mg
162: 261–268.per day.25 Further trials of combination therapies of
14 Rothe G, Oser A, Valet G. Dihydrorhodamine-123 a new flowvitamin C with other antioxidant vitamins, minerals cytometric indicator for respiratory burst activity in neutrophil
granulocytes. Naturwissenschaften 1988; 75: 354–355.and amino acids may allow dose reduction, should
15 Khaira H, Maxwell S, Thompson H et al. Antioxidant depletionthis prove to be of concern in the long term. In addition,
during aortic aneurysm repair. Br J Surg 1996; 83: 401–403.our study would suggest that short-term therapy, such 16 Spark J, Chetter C, Gallavin L et al. Reduced total antioxidant
capacity predicts ischaemia-reperfusion injury after femoro-as five days, may be of benefit.
distal bypass. Br J Surg 1998; 85: 221–225.In summary, this study demonstrates that short-term
17 Hoshino E, Shariff R, Van Gossum A et al. Vitamin E sup-oral therapy with vitamin C attenuates reperfusion- presses increased lipid peroxidation in cigarette smokers. J Par-
enter Enteral Nutr 1990; 14: 300–305.induced pulmonary injury. While a clinical study can-
18 Levine M, Conry-Cantilena C, Wang Y et al. Vitamin Cnot be advocated on the basis of this study in isolation,
pharmacokinetics in healthy volunteers: evidence for a re-it does suggest the need for further evaluation of commended daily allowance. Proc Natl Acad Sci USA 1996; 93:
3704–3709.vitamin C’s mechanism of action and possible clinical
19 Mirvish SS. Effects of Vitamin C and E on N-Nitroso Compoundvalue.
Formation, Carcinogenesis, and Cancer. Cancer 1986; 58: 1842–
1850.
20 Herbaczynska-Cedro K, Wartanowicz M, Panczenko-Acknowledgements
Kresowska B et al. Inhibitory effect of vitamins C and E on the
oxygen free radical production in human polymorphonuclearThis study was supported by a research grant from the Jervis Street
leucocytes. Eur J Clin Invest 1994; 24: 316–319.Charitable Infirmary Charitable Trust, Dublin, Ireland.
21 Kaufman MJ. Comparison of the free radical-scavenging abilityI would like to thank Nick O’Connor, Derek Borwick, Martin and
of captopril and ascorbic acid in an in-vitro model of lipidDr. Chen Gang, who all helped me greatly in completing this work.
oxidation. Implications for reperfusion injury and ACE inhibitor
therapy. J Pharm & Pharmacol 1994; 46: 217–220.
22 Jialal I, Grundy SM. Preservation of the endogenous anti-
References oxidants in low density lipoprotein by ascorbate but not by
probucol during oxidative modification. J Clin Invest 1991; 87:
597–601.1 Paterson IS, Corson J, McCollum CN et al. Multiple organ
23 Kagan VE, Serbinova EA, Forte T et al. Recycling of vitaminfailure following abdominal aortic aneurysm repair. Br J Surg
E in human low density lipoproteins. J Lipid Res 1992; 33: 385–397.1992; 76: 358.
24 Podmore ID, Griffiths HR, Herbert KE et al. Vitamin C exhibits2 Paterson IS, Klausner JM, Pugatch R et al. Noncardiogenic
pro-oxidant properties. Nature 1998; 302: 559.pulmonary oedema after abdominal aortic aneurysm surgery.
25 Bendich A, Langseth L. The health effects of vitamin C sup-Ann Surg 1989; 108: 231–236.
plementation: a review. J Am Coll Nutr 1995; 14: 124–136.3 Klausner JM, Anner H, Paterson IS et al. Lower torso isch-
aemia-induced lung injury is leukocyte dependent. Ann Surg
1983; 208: 762–767. Accepted 28 January 1999
Eur J Vasc Endovasc Surg Vol 17, June 1999
